Trending
Prev Story
Next Story

EQT appoints sell-side advisers for $5b Icon Cancer Care sale

The Australian Financial Review (AFR) •
November 12, 2026 • 12:02 AM
1
1 reads 0 reactions

Should a sale to private equity or trade be the chosen exit route, a valuation of around $5 billion would be sought, the sources said.

EQT appoints sell-side advisers for $5b Icon Cancer Care sale

Swedish private equity firm EQT has set the wheels in motion for a payday at Icon Group, the Australian cancer care provider it acquired for $2.3 billion in 2021.

Investment banks Barrenjoey Capital Partners and Goldman Sachs have been hired to consider strategic options for the business, according to people briefed on the matter but who were unauthorised to speak on the record.

Gift articles to anyone you choose each month when you subscribe.

Prev Swipe Story Next

Related Stories

Technology
Build #2611